List of Tables
Table 1. Global Specific Thrombolytic Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Specific Thrombolytic Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Specific Thrombolytic Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Specific Thrombolytic Drugs Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Specific Thrombolytic Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Specific Thrombolytic Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Specific Thrombolytic Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Specific Thrombolytic Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Specific Thrombolytic Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Specific Thrombolytic Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Specific Thrombolytic Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Specific Thrombolytic Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Specific Thrombolytic Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Specific Thrombolytic Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Specific Thrombolytic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Specific Thrombolytic Drugs Sales by Region (Units), 2021–2026
Table 18. Global Specific Thrombolytic Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Specific Thrombolytic Drugs Sales by Region (Units), 2027–2032
Table 20. Global Specific Thrombolytic Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Specific Thrombolytic Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Specific Thrombolytic Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Specific Thrombolytic Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Specific Thrombolytic Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Specific Thrombolytic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Specific Thrombolytic Drugs Sales by Country (Units), 2021–2026
Table 27. North America Specific Thrombolytic Drugs Sales by Country (Units), 2027–2032
Table 28. North America Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Specific Thrombolytic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Specific Thrombolytic Drugs Sales by Country (Units), 2021–2026
Table 32. Europe Specific Thrombolytic Drugs Sales by Country (Units), 2027–2032
Table 33. Europe Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Specific Thrombolytic Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Specific Thrombolytic Drugs Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Specific Thrombolytic Drugs Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Specific Thrombolytic Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Specific Thrombolytic Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Specific Thrombolytic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Specific Thrombolytic Drugs Sales by Country (Units), 2021–2026
Table 42. Latin America Specific Thrombolytic Drugs Sales by Country (Units), 2027–2032
Table 43. Latin America Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Specific Thrombolytic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Specific Thrombolytic Drugs Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Specific Thrombolytic Drugs Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Specific Thrombolytic Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Specific Thrombolytic Drugs Sales (Units) by Type (2021–2026)
Table 51. Global Specific Thrombolytic Drugs Sales (Units) by Type (2027–2032)
Table 52. Global Specific Thrombolytic Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Specific Thrombolytic Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Specific Thrombolytic Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Specific Thrombolytic Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Specific Thrombolytic Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Specific Thrombolytic Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Specific Thrombolytic Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Specific Thrombolytic Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Specific Thrombolytic Drugs Sales (Units) by Application (2021–2026)
Table 61. Global Specific Thrombolytic Drugs Sales (Units) by Application (2027–2032)
Table 62. Global Specific Thrombolytic Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Specific Thrombolytic Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Specific Thrombolytic Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Specific Thrombolytic Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Specific Thrombolytic Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Specific Thrombolytic Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Specific Thrombolytic Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Specific Thrombolytic Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Genentech Company Information
Table 71. Genentech Description and Business Overview
Table 72. Genentech Specific Thrombolytic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Genentech Specific Thrombolytic Drugs Product
Table 74. Genentech Recent Developments/Updates
Table 75. Boehringer Mannheim Company Information
Table 76. Boehringer Mannheim Description and Business Overview
Table 77. Boehringer Mannheim Specific Thrombolytic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boehringer Mannheim Specific Thrombolytic Drugs Product
Table 79. Boehringer Mannheim Recent Developments/Updates
Table 80. Emcure Pharmaceuticals Company Information
Table 81. Emcure Pharmaceuticals Description and Business Overview
Table 82. Emcure Pharmaceuticals Specific Thrombolytic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Emcure Pharmaceuticals Specific Thrombolytic Drugs Product
Table 84. Emcure Pharmaceuticals Recent Developments/Updates
Table 85. Rewine pharmaceuticals Company Information
Table 86. Rewine pharmaceuticals Description and Business Overview
Table 87. Rewine pharmaceuticals Specific Thrombolytic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Rewine pharmaceuticals Specific Thrombolytic Drugs Product
Table 89. Rewine pharmaceuticals Recent Developments/Updates
Table 90. Gennova Bio Company Information
Table 91. Gennova Bio Description and Business Overview
Table 92. Gennova Bio Specific Thrombolytic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Gennova Bio Specific Thrombolytic Drugs Product
Table 94. Gennova Bio Recent Developments/Updates
Table 95. Tasly Pharma Company Information
Table 96. Tasly Pharma Description and Business Overview
Table 97. Tasly Pharma Specific Thrombolytic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Tasly Pharma Specific Thrombolytic Drugs Product
Table 99. Tasly Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Specific Thrombolytic Drugs Distributors List
Table 103. Specific Thrombolytic Drugs Customers List
Table 104. Specific Thrombolytic Drugs Market Trends
Table 105. Specific Thrombolytic Drugs Market Drivers
Table 106. Specific Thrombolytic Drugs Market Challenges
Table 107. Specific Thrombolytic Drugs Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Specific Thrombolytic Drugs
Figure 2. Global Specific Thrombolytic Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Specific Thrombolytic Drugs Market Share by Type: 2025 & 2032
Figure 4. Alteplase Product Picture
Figure 5. Prourokinase Product Picture
Figure 6. Tenecteplase Product Picture
Figure 7. Others Product Picture
Figure 8. Global Specific Thrombolytic Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Specific Thrombolytic Drugs Market Share by Application: 2025 & 2032
Figure 10. Venous Thrombosis
Figure 11. Arterial Thrombosis
Figure 12. Others
Figure 13. Global Specific Thrombolytic Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Specific Thrombolytic Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Specific Thrombolytic Drugs Sales (Units), 2021–2032
Figure 16. Global Specific Thrombolytic Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Specific Thrombolytic Drugs Report Years Considered
Figure 18. Specific Thrombolytic Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Specific Thrombolytic Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Specific Thrombolytic Drugs Players: Market Share by Revenue in Specific Thrombolytic Drugs in 2025
Figure 21. Specific Thrombolytic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Specific Thrombolytic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Specific Thrombolytic Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Specific Thrombolytic Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Specific Thrombolytic Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Specific Thrombolytic Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Specific Thrombolytic Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Specific Thrombolytic Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Specific Thrombolytic Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Specific Thrombolytic Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Specific Thrombolytic Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Specific Thrombolytic Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Specific Thrombolytic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Specific Thrombolytic Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Specific Thrombolytic Drugs by Type (2021–2032)
Figure 56. Global Specific Thrombolytic Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Specific Thrombolytic Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Specific Thrombolytic Drugs by Application (2021–2032)
Figure 59. Global Specific Thrombolytic Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Specific Thrombolytic Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
